No Red Envelopes As MRs Granted New China Recognition
This article was originally published in PharmAsia News
Executive Summary
The exchange of red envelopes containing gifts or money, considered customary during the Lunar New Year celebrations in China, is becoming an outdated practice as far as medical reps and physicians go, amid ever-increasing ethical scrutiny and government efforts to restore the reputation of a tarnished profession.
You may also be interested in...
China Imposes Tough New Curbs On Rep Sales Activities
Tough new rules from China’s State Council have put the country’s one million medical reps into limbo as their employers scrabble to get to grips with broad curbs on sales activities.
2016 Review: Pricing, R&D Issues Dominate China Commercial Arena
2016 was again another busy year on the commercial front in China, with market changes, new regulations, and ongoing pricing pressures all affecting the pharma sector. Meanwhile, the push for licensing deals, innovation, and international expansion continued apace.
Medtechs Must Reflect On China Localization Policies As VBP Expands
China continues to roll out volume-based procurement for medical devices and pharma products and companies should plan their strategies accordingly, advises EY Parthenon’s Hua Su.